By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


Key Statistics

Ownership: Public

Web Site: Imprimis
Symbol: immy

Company News
Imprimis (immy) Announces First Quarter 2017 Financial Results 5/11/2017 8:34:27 AM
Imprimis (immy) And SightLife Surgical Sign Agreement For National Launch Of Serum Tears 5/2/2017 7:00:45 AM
Imprimis (immy) To Host Its First Quarter 2017 Financial Report Conference Call And Webcast On May 10, 2017 At 4:15 P.M. EDT 5/1/2017 8:49:12 AM
Imprimis (immy) And Precision Lens Sign Agreement To Expand Imprimis' Ophthalmic Portfolio Market Opportunity In The U.S. Midwest 4/18/2017 6:54:30 AM
Imprimis (immy) Acquires Exclusive License To Patented Ophthalmic Formulation For Dry Eye Disease 4/6/2017 8:29:19 AM
Imprimis (immy) Announces Fourth Quarter And Year-End 2016 Financial Results 3/22/2017 10:08:13 AM
Imprimis (immy) To Raise $3.1 Million In Registered Direct Offering 3/22/2017 7:30:17 AM
Imprimis (immy) Release: Peer-Reviewed Paper Demonstrates The Benefits Of Dropless Cataract Surgery 3/20/2017 11:12:06 AM
Imprimis (immy) Begins Dispensing from FDA-Registered 503B Outsourcing Facility 2/16/2017 6:35:08 AM
Imprimis (immy) And FocusScript Partner To Exclusively Offer The Correct Compound Program 12/21/2016 12:22:57 PM